Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCDC106 | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | FAM98B | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | EPM2A | CTRPv2 | pan-cancer | AAC | 0.41 | 0.002 |
mRNA | TBC1D3C | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
mRNA | FH | CTRPv2 | pan-cancer | AAC | 0.36 | 0.002 |
mRNA | TBC1D3D | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
mRNA | TRPC4AP | CTRPv2 | pan-cancer | AAC | -0.33 | 0.002 |
mRNA | RAD54L | CTRPv2 | pan-cancer | AAC | 0.37 | 0.002 |
mRNA | SEMA5A | CTRPv2 | pan-cancer | AAC | -0.36 | 0.002 |
mRNA | ARMC6 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.002 |